作者: Peter Traxler , Kurt Sizer , Debra Resta
DOI:
关键词:
摘要: This disclosure relates to the treatment of cancer, particularly breast with a combination an aromatase inhibitor, such as letrozole, and compound that inhibits tyrosine kinase activity epidermal growth factor (EGF). Methods pharmaceutical compositions are included in disclosure.